Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Ribavirin in the treatment of SARS: A new trick for an old drug?

Literature DB >> 12743076

Ribavirin in the treatment of SARS: A new trick for an old drug?

Gideon Koren¹, Susan King, Sandra Knowles, Elizabeth Phillips.

Abstract

Entities: Chemical Gene

Mesh：

Substances：

Year: 2003 PMID： 12743076 PMCID： PMC154189

Source DB: PubMed Journal: CMAJ ISSN： 0820-3946 Impact factor: 8.262

× No keyword cloud information.

13 in total

1. The safety and tolerability of daily infergen plus ribavirin in the treatment of naíïve chronic hepatitis C patients.

Authors: P J Pockros; R Reindollar; J McHutchinson; R Reddy; T Wright; D G Boyd; L B Wilkes
Journal: J Viral Hepat Date: 2003-01 Impact factor: 3.728

2. Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome.

Authors: J W Huggins; C M Hsiang; T M Cosgriff; M Y Guang; J I Smith; Z O Wu; J W LeDuc; Z M Zheng; J M Meegan; Q N Wang
Journal: J Infect Dis Date: 1991-12 Impact factor: 5.226

3. Exposure of pregnant women to ribavirin-contaminated air: risk assessment and recommendations.

Authors: S Ito; G Koren
Journal: Pediatr Infect Dis J Date: 1993-01 Impact factor: 2.129

Review 4. The clinical pharmacology of ribavirin.

Authors: P Glue
Journal: Semin Liver Dis Date: 1999 Impact factor: 6.115

5. Increased mitochondrial toxicity with ribavirin in HIV/HCV coinfection.

Authors: A Lafeuillade; G Hittinger; S Chadapaud
Journal: Lancet Date: 2001-01-27 Impact factor: 79.321

Review 6. Adverse effects and other safety aspects of the hepatitis C antivirals.

Authors: A Chutaputti
Journal: J Gastroenterol Hepatol Date: 2000-05 Impact factor: 4.029

Review 7. The mechanism of action of ribavirin: lethal mutagenesis of RNA virus genomes mediated by the viral RNA-dependent RNA polymerase.

Authors: C E Cameron; C Castro
Journal: Curr Opin Infect Dis Date: 2001-12 Impact factor: 4.915

8. Intravenous ribavirin and hyperammonemia in an immunocompromised patient infected with adenovirus.

Authors: P Bertrand; A Faro; P Cantwell; A Tzakis
Journal: Pharmacotherapy Date: 2000-10 Impact factor: 4.705

Review 9. Meta-analysis: ribavirin-induced haemolytic anaemia in patients with chronic hepatitis C.

Authors: C H Chang; K Y Chen; M Y Lai; K A Chan
Journal: Aliment Pharmacol Ther Date: 2002-09 Impact factor: 8.171

10. Intravenous ribavirin for hantavirus pulmonary syndrome: safety and tolerance during 1 year of open-label experience. Ribavirin Study Group.

Authors: L E Chapman; G J Mertz; C J Peters; H M Jolson; A S Khan; T G Ksiazek; F T Koster; K F Baum; P E Rollin; A T Pavia; R C Holman; J C Christenson; P J Rubin; R E Behrman; L J Bell; G L Simpson; R F Sadek
Journal: Antivir Ther Date: 1999

50 in total

1. SARS update.

Authors: James Maskalyk; John Hoey
Journal: CMAJ Date: 2003-05-13 Impact factor: 8.262

2. SARS: the struggle for containment.

Authors:
Journal: CMAJ Date: 2003-05-13 Impact factor: 8.262

Review 3. Antiviral treatment of SARS: can we draw any conclusions?

Authors: Getu Zhaori
Journal: CMAJ Date: 2003-11-25 Impact factor: 8.262

4. Controversies' clarification regarding ribavirin efficacy in measles and coronaviruses: Comprehensive therapeutic approach strictly tailored to COVID-19 disease stages.

Authors: George D Liatsos
Journal: World J Clin Cases Date: 2021-07-06 Impact factor: 1.337

Review 5. Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus.

Authors: Susan R Weiss; Sonia Navas-Martin
Journal: Microbiol Mol Biol Rev Date: 2005-12 Impact factor: 11.056

6. Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS).

Authors: J W M Chan; C K Ng; Y H Chan; T Y W Mok; S Lee; S Y Y Chu; W L Law; M P Lee; P C K Li
Journal: Thorax Date: 2003-08 Impact factor: 9.139